Johnson & Johnson (JNJ) Meets EPS Estimate, Beats on Revenue; Offers FY Guidance
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $268.70 +0.53%
EPS Growth %: +3.6%
Financial Fact:
Provision for taxes on income (Note 5): 1.01B
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: +3.6%
Financial Fact:
Provision for taxes on income (Note 5): 1.01B
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
(Updated - January 21, 2026 8:28 AM EST)
Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $2.46, in line with the analyst estimate of $2.46. Revenue for the quarter came in at $24.6 billion versus the consensus estimate of $24.15 billion.
GUIDANCE:
Johnson & Johnson sees FY2026 EPS of $11.43-$11.63, versus the consensus of $11.49. Johnson & Johnson sees FY2026 revenue of $100-101 billion, versus the consensus of $98.9 billion.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jackson Financial Inc. (JXN) Mentioned as Short at Bear Cave
- BetterLife Pharma closes $100M public offering on Canadian exchange
- Electra Is Said to Guide IPO Pricing to Upper Half of Range
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
